학술논문

A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer
Document Type
Article
Source
In ESMO Open June 2023 8(3)
Subject
Language
ISSN
2059-7029